Rexahn Pharmaceuticals Company
Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Rockville, Maryland, United States
Founded Date:
2001
Estimated Revenue:
$1M to $10M
Register and Claim Ownership